The incidence and prevalence of Huntington's disease (HD) based on a systematic review
and meta‐analysis of 20 studies published from 1985 to 2010 was estimated at 0.38 per …

Neurodegeneration is the loss of neuronal capacity and structure over time which causes
neurodegenerative disorders like Alzheimer, amyotrophic lateral sclerosis, Parkinson, and …

Huntington's Disease (HD) is a severely debilitating neurodegenerative disorder in which
sufferers exhibit different combinations of movement disorders, dementia, and behavioral or …

Background Huntington's disease is an inherited progressive neurodegenerative disorder
caused by an expansion of the polyglutamine tract leading to malformation and aggregation …

Modern pharmacotherapy of neurodegenerative diseases is predominantly symptomatic
and does not allow vicious circles causing disease development to break. Protein misfolding …

Background: Huntington's disease (HD) poses a significant socio-economic burden globally.
Existing research on HD's economic burden predominantly comes from Western settings …

Abstract Background Latin America has played a crucial role in advancing our
understanding of Huntington's disease (HD). However, previous global reviews include …

Background Huntington's disease (HD) is an autosomal dominant neurodegenerative
disease, characterized by progressive motor, cognitive, and psychiatric symptoms. The …

Background Huntington's disease (HD) is a rare, neurodegenerative disease and its
complex motor, cognitive and psychiatric symptoms exert a lifelong clinical burden on both …

Objectives Pharmacologic treatment of type 2 diabetes mellitus (T2DM) follows a stepwise
approach. Typically, metformin monotherapy is first-line treatment, followed by other …